{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:28:01Z","timestamp":1791232081393,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010489","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000}}],"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick-borne infectious disease with high case fatality rate. Unfortunately, no vaccine or antiviral specifically targeting SFTS virus (SFTSV) are available for the time being. Our objective was to investigate the association between clinical laboratory parameters and fatality of SFTS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The systematic review was conducted in accordance with The Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. We searched (from inception to 24th February 2022) Web of Science, PubMed, National Knowledge Infrastructure databases and Wan Fang Data for relevant researchers on SFTS. Studies were eligible if they reported on laboratory parameters of SFTS patients and were stratified by clinical outcomes. A modified version of Newcastle-Ottawa scale was used to evaluate the quality of included studies. Standardized mean difference (SMD) was used to evaluate the association between laboratory parameters and outcomes. The between-study heterogeneity was evaluated quantitatively by standard Chi-square and the index of heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      ). Heterogeneity was explored by subgroup and sensitivity analyses, and univariable meta-regression. Publication bias was determined using funnel plots and Egger\u2019s test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified 34 relevant studies, with over 3300 participants across three countries. The following factors were strongly (SMD&gt;1 or SMD&lt;-0.5) and significantly (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.05) associated mortality: thrombin time (TT) (SMD = 1.53), viral load (SMD = 1.47), activated partial-thromboplastin time (APTT) (SMD = 1.37), aspartate aminotransferase (AST) (SMD = 1.19), lactate dehydrogenase (LDH) (SMD = 1.13), platelet count (PLT) (SMD = -0.47), monocyte percentage (MON%) (SMD = -0.47), lymphocyte percentage (LYM%) (SMD = -0.46) and albumin (ALB) (SMD = -0.43). Alanine aminotransferase, AST, creatin phosphokinase, LDH, PLT, partial-thromboplastin time and viral load contributed to the risk of dying of SFTS patients in each subgroup analyses. Sensitivity analysis demonstrated that the results above were robust.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions\/significance<\/jats:title>\n                    <jats:p>The abnormal levels of viral load, PLT, coagulation function and liver function, significantly increase the risk of SFTS mortality, suggesting that SFTS patients with above symptoms call for special concern.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0010489","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:36:32Z","timestamp":1655472992000},"page":"e0010489","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Clinical laboratory parameters and fatality of Severe fever with thrombocytopenia syndrome patients: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5694-0021","authenticated-orcid":true,"given":"Hongling","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"10","key":"pntd.0010489.ref001","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011\u20132017: a prospective observational study","volume":"18","author":"H Li","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"pntd.0010489.ref002","doi-asserted-by":"crossref","first-page":"e3851","DOI":"10.1093\/cid\/ciaa1561","article-title":"Epidemiology and Ecology of Severe Fever with Thrombocytopenia Syndrome in China, 2010\u20132018","volume":"73","author":"D Miao","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"pntd.0010489.ref003","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/1040841X.2020.1847037","article-title":"Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus","volume":"47","author":"J Li","year":"2021","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"pntd.0010489.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.epidem.2012.09.002","article-title":"Evolutionary and molecular analysis of the emergent severe fever with thrombocytopenia syndrome virus","volume":"5","author":"TT Lam","year":"2013","journal-title":"Epidemics"},{"issue":"9","key":"pntd.0010489.ref005","doi-asserted-by":"crossref","first-page":"e171427","DOI":"10.3201\/eid2409.171427","article-title":"World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development","volume":"24","author":"MS Mehand","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"pntd.0010489.ref006","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12985-016-0661-9","article-title":"Meta-analysis of the clinical and laboratory parameters of SFTS patients in China","volume":"13","author":"MM Li","year":"2016","journal-title":"Virol J"},{"issue":"6","key":"pntd.0010489.ref007","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/jmv.26518","article-title":"Clinical manifestations of death with severe fever and thrombocytopenia syndrome: A meta-analysis and systematic review","volume":"93","author":"X Wang","year":"2021","journal-title":"J Med Virol"},{"key":"pntd.0010489.ref008","doi-asserted-by":"crossref","first-page":"102501","DOI":"10.1016\/j.amsu.2021.102501","article-title":"Factors and outcomes in Severe Fever with Thrombocytopenia Syndrome (SFTS): A systematic review","volume":"67","author":"H Dualis","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"pntd.0010489.ref009","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12879-020-05303-0","article-title":"Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes","volume":"20","author":"Z He","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pntd.0010489.ref010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13643-021-01753-y","article-title":"The prevalence of tuberculosis, malaria and soil-transmitted helminth infection in minority indigenous people of Southeast Asia and the Western Pacific: protocol for a systematic review and meta-analysis","volume":"10","author":"B Gilmour","year":"2021","journal-title":"Syst Rev"},{"key":"pntd.0010489.ref011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"SP Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"pntd.0010489.ref012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"X Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"pntd.0010489.ref013","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"C Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"pntd.0010489.ref014","first-page":"48","article-title":"Application of Stata in Exploring Sources of Heterogeneity: Meta-Regression Analysis","volume":"9","author":"TS Zhang","year":"2009","journal-title":"The Journal of Evidence-Based Medicine"},{"issue":"5","key":"pntd.0010489.ref015","first-page":"94","article-title":"The clinical characteristics and prognostic indicators of severe fever with thrombocytopenia syndrome infected by new Bunia virus","volume":"14","author":"GS Chen","year":"2017","journal-title":"China Medical Equipment"},{"issue":"6","key":"pntd.0010489.ref016","first-page":"526","article-title":"Clinical characteristics of 40 patients with severe fever with thrombocytopenia syndrome in Tiantai County","volume":"46","author":"SS Chu","year":"2019","journal-title":"Inter J Epidemiol Infect Dis"},{"key":"pntd.0010489.ref017","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.2147\/JIR.S335727","article-title":"Predictive Value of the Platelet-to-Albumin Ratio (PAR) on the Risk of Death at Admission in Patients Suffering from Severe Fever with Thrombocytopenia Syndrome","volume":"14","author":"Y Gui","year":"2021","journal-title":"J Inflamm Res"},{"issue":"2","key":"pntd.0010489.ref018","first-page":"171187","article-title":"Epidemiological characteristics of severe fever with thrombocytopenia syndrome caused by novel bunyavirus infection and influencing factors for prognosis","volume":"29","author":"CX Han","year":"2019","journal-title":"Chin J Nosocomiol"},{"issue":"10","key":"pntd.0010489.ref019","first-page":"897","article-title":"Clinical characteristics and influencing factors for prognosis of fever with severe thrombocytopenia syndrome in Dalian, Liaoning Province","volume":"20","author":"HH Hou","year":"2021","journal-title":"Chin J Infect Control"},{"issue":"9","key":"pntd.0010489.ref020","doi-asserted-by":"crossref","first-page":"e0005909","DOI":"10.1371\/journal.pntd.0005909","article-title":"A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome","volume":"11","author":"B Jia","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0010489.ref021","doi-asserted-by":"crossref","first-page":"e0165207","DOI":"10.1371\/journal.pone.0165207","article-title":"SFTS epidemiological research group-Japan. Epidemiological and Clinical Features of Severe Fever with Thrombocytopenia Syndrome in Japan, 2013\u20132014","volume":"11","author":"H Kato","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"pntd.0010489.ref022","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.3390\/v13122351","article-title":"Viral and Immunologic Factors Associated with Fatal Outcome of Patients with Severe Fever with Thrombocytopenia in Korea","volume":"13","author":"JS Kwon","year":"2021","journal-title":"Virus"},{"issue":"3","key":"pntd.0010489.ref023","doi-asserted-by":"crossref","first-page":"e91679","DOI":"10.1371\/journal.pone.0091679","article-title":"Concurrent measurement of dynamic changes in viral load, serum enzymes, T cell subsets, and cytokines in patients with severe fever with thrombocytopenia syndrome","volume":"9","author":"J Li","year":"2014","journal-title":"PLoS One"},{"key":"pntd.0010489.ref024","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2018.07.009","article-title":"CD4 T cell loss and Th2 and Th17 bias are associate with the severity of severe fever with thrombocytopenia syndrome (SFTS)","volume":"195","author":"MM Li","year":"2018","journal-title":"Clin Immunol"},{"issue":"5","key":"pntd.0010489.ref025","first-page":"429","article-title":"Analysis of clinical characteristics and death risk factors in patients infected with severe fever with thrombocytopenia syndrome bunyavirus","volume":"41","author":"JY Liu","year":"2018","journal-title":"Chin J Postgrad Med"},{"issue":"9","key":"pntd.0010489.ref026","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cid\/cit530","article-title":"Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome","volume":"57","author":"W Liu","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"pntd.0010489.ref027","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/SHK.0000000000001527","article-title":"Analysis of Severe Fever With Thrombocytopenia Syndrome in Critical Ill Patients in Central China","volume":"54","author":"Q Nie","year":"2020","journal-title":"Shock"},{"key":"pntd.0010489.ref028","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2015.12.009","article-title":"Decreased monocyte subsets and TLR4-mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS)","volume":"43","author":"C Peng","year":"2016","journal-title":"Int J Infect Dis"},{"key":"pntd.0010489.ref029","first-page":"152","article-title":"Clinical characteristics and prognostic factors of 25 patients with new bunyavirus infection","volume":"12","author":"QY Sheng","year":"2019","journal-title":"Chin J Crit Care Med (Electronic Edition)"},{"key":"pntd.0010489.ref030","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.3201\/eid2110.141928","article-title":"Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome, South Korea, 2013","volume":"21","author":"J Shin","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"pntd.0010489.ref031","doi-asserted-by":"crossref","first-page":"e0009103","DOI":"10.1371\/journal.pntd.0009103","article-title":"A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome","volume":"15","author":"K Suemori","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0010489.ref032","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10238-013-0259-0","article-title":"Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome","volume":"14","author":"L Sun","year":"2014","journal-title":"Clin Exp Med"},{"issue":"7","key":"pntd.0010489.ref033","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/infdis\/jis452","article-title":"Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome","volume":"206","author":"Y Sun","year":"2012","journal-title":"J Infect Dis"},{"key":"pntd.0010489.ref034","first-page":"70","article-title":"Epidemiology, clinical characteristics and gene sequence of fatal cases of severe fever with thrombocytopenia syndrome in Zhoushan island, China","volume":"32","author":"QL Tan","year":"2016","journal-title":"Chinese Journal of Zoonoses"},{"key":"pntd.0010489.ref035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/IJGM.S292735","article-title":"Risk Factors and Clinical Characteristics of Severe Fever with Thrombocytopenia Syndrome","volume":"13","author":"F Wang","year":"2020","journal-title":"Int J Gen Med"},{"issue":"11","key":"pntd.0010489.ref036","doi-asserted-by":"crossref","first-page":"e0007829","DOI":"10.1371\/journal.pntd.0007829","article-title":"A nomogram to predict mortality in patients with severe fever with thrombocytopenia syndrome at the early stage-A multicenter study in China","volume":"13","author":"L Wang","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0010489.ref037","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12879-020-05299-7","article-title":"Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system","volume":"20","author":"L Wang","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"1","key":"pntd.0010489.ref038","first-page":"16","article-title":"Clinical characteristics and treatment efficacy of sever infection caused by new bunyaviridae","volume":"5","author":"LY Xiao","year":"2020","journal-title":"Electronic Journal of Emerging Infectious Diseases"},{"issue":"52","key":"pntd.0010489.ref039","doi-asserted-by":"crossref","first-page":"e5708","DOI":"10.1097\/MD.0000000000005708","article-title":"A simple and practical score model for predicting the mortality of severe fever with thrombocytopenia syndrome patients","volume":"95","author":"S Xiong","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pntd.0010489.ref040","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1620\/tjem.242.19","article-title":"A Newly Established Severity Scoring System in Predicting the Prognosis of Patients with Severe Fever with Thrombocytopenia Syndrome","volume":"242","author":"B Yang","year":"2017","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"pntd.0010489.ref041","first-page":"402","article-title":"Investigation of clinical characteristics and prognosis of severe fever with thrombocytopenia syndrome: 69 cases analysis","volume":"22","author":"M Yang","year":"2018","journal-title":"Chin J Dis Control Prev"},{"issue":"4","key":"pntd.0010489.ref042","first-page":"2125","article-title":"Risk factors for death in 95 patients with fever and thrombocytopenia syndrome","volume":"19","author":"M Yin","year":"2020","journal-title":"Journal of Anhui Health Vocational & Technical College"},{"key":"pntd.0010489.ref043","doi-asserted-by":"crossref","first-page":"711847","DOI":"10.3389\/fimmu.2021.711847","article-title":"IL-6 and IL-10 Levels, Rather Than Viral Load and Neutralizing Antibody Titers, Determine the Fate of Patients With Severe Fsver With Thrombocytopenia Syndrome Virus Infection in South Korea","volume":"12","author":"JR Yoo","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"pntd.0010489.ref044","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10096-020-04098-x","article-title":"Epidemiological characteristics of severe fever with thrombocytopenia syndrome in surveillance study from 2011 to 2018","volume":"40","author":"EQ You","year":"2021","journal-title":"Eur J Clin Microboil Infect Dis"},{"issue":"6","key":"pntd.0010489.ref045","first-page":"336","article-title":"Risk factors for mortality in patients with severe fever with thrombocytopenia syndrome","volume":"35","author":"QQ Zeng","year":"2017","journal-title":"Chin J Infect Dis"},{"issue":"4","key":"pntd.0010489.ref046","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cir804","article-title":"Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome","volume":"54","author":"YZ Zhang","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pntd.0010489.ref047","first-page":"537","article-title":"Serum cytokines and chemokines in patients with severe fever with thrombocytopenia syndrome","volume":"34","author":"H Zhao","year":"2020","journal-title":"Chinese J Exp Clin Virol"},{"issue":"6","key":"pntd.0010489.ref048","first-page":"942","article-title":"Clinical characteristics and prognostic factors of patients infected with novel Bunyavirus","volume":"56","author":"SJ Zhou","year":"2021","journal-title":"Acta Universitatis Medicinalis Anhui"},{"key":"pntd.0010489.ref049","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcv.2016.03.017","article-title":"The prospective evaluation of viral loads in patients with severe fever with thrombocytopenia syndrome","volume":"78","author":"ZD Yang","year":"2016","journal-title":"J Clin Virol"},{"issue":"8","key":"pntd.0010489.ref050","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1002\/jmv.26877","article-title":"Changes in peripheral blood cytokines in patients with severe fever with thrombocytopenia syndrome","volume":"93","author":"Z He","year":"2021","journal-title":"J Med Virol"},{"issue":"1","key":"pntd.0010489.ref051","first-page":"12","article-title":"Etiology and pathogenesis of coronavirus","volume":"5","author":"YP Li","year":"2020","journal-title":"Clinical Research and Practice"},{"issue":"9","key":"pntd.0010489.ref052","first-page":"538","article-title":"Viral load and cytokines in the pathogenesis of severe fever with thrombocytopenia syndrome","volume":"32","author":"YP Han","year":"2014","journal-title":"Chin J Infect Dis"},{"issue":"14","key":"pntd.0010489.ref053","first-page":"2054","article-title":"Risk factors predicting fatality of severe fever complicated with thrombocytopenia syndrome: a meta-analysis[J]","volume":"26","author":"Z Yu","year":"2020","journal-title":"IMHGN"},{"issue":"25","key":"pntd.0010489.ref054","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1073\/pnas.1120246109","article-title":"Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model","volume":"109","author":"C Jin","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"pntd.0010489.ref055","first-page":"32313236","article-title":"Clinical characteristics and prognostic factors of new bunia viral infection","volume":"36","author":"YQ Ma","year":"2020","journal-title":"The Journal of Practical Medicine"},{"issue":"1","key":"pntd.0010489.ref056","first-page":"15","article-title":"Clinical characteristics and risk factors for mortality of patients with severe fever with thrombocytopenia syndrome","volume":"34","author":"HY Zhao","year":"2016","journal-title":"Chin J Infect Dis"},{"key":"pntd.0010489.ref057","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/500836","article-title":"Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever","volume":"193","author":"O Ergonul","year":"2006","journal-title":"J Infect Dis"},{"issue":"10","key":"pntd.0010489.ref058","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1473-3099(18)30312-8","article-title":"Risk factors for death in severe fever with thrombocytopenia syndrome","volume":"18","author":"XJ Yu","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pntd.0010489.ref059","first-page":"370","article-title":"Prognostic value of laboratory parameters in patients with severe fever thrombocytopenia syndrome","volume":"44","author":"L Wang","year":"2017","journal-title":"Inter J Epidemiol Infect Dis"},{"issue":"6","key":"pntd.0010489.ref060","first-page":"34","article-title":"Characteristics and significances of ECG in patients of severe fever with thrombocytopenia syndrome","volume":"9","author":"F Shao","year":"2015","journal-title":"Chin J Exp Clin Dis (Electronic Edition)"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010489","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:51:08Z","timestamp":1656597068000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010489"}},"subtitle":[],"editor":[{"given":"Michael R.","family":"Holbrook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010489","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]}}}